Monitor the next quarterly filing for any change in accounting policies or restatements under the new auditor, though no adverse signals were flagged in this notice.
Price Chart
Executive Summary
NervGen Pharma Corp. filed a Form 6-K announcing the resignation of KPMG Canada as its auditor and the appointment of KPMG US, effective September 15, 2026. The company states there were no modified opinions or reportable events during the prior two fiscal years. This is a routine auditor change with no adverse financial disclosures.
Key Facts
- KPMG Canada resigned as auditor effective September 15, 2026, at the company's request.
- KPMG US was appointed as the new auditor, effective the same date.
- No modified audit opinions were issued by KPMG Canada for the two most recently completed fiscal years.
- The company states there were no reportable events (as defined in NI 51-102) during that period.
- The change was approved by the audit committee and board of directors.
Financial Impact
No financial impact disclosed; auditor change is administrative in nature.
Risk Factors
- Auditor changes can sometimes precede accounting disagreements or restatements, though none are indicated here.
- The US auditor may impose different materiality thresholds or disclosure requirements.
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-110225 |
| Document: tm2625558d1_6k.htm | 0001104659-26-110225 |
| Document: tm2625558d1_ex99-1.htm | 0001104659-26-110225 |
| Document: tm2625558d1_ex99-3.htm | 0001104659-26-110225 |
| Document: 0001104659-26-110225-index-headers.html | 0001104659-26-110225 |
| Document: 0001104659-26-110225-index.html | 0001104659-26-110225 |
| Document: 0001104659-26-110225.txt | 0001104659-26-110225 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | 6-K | $1.88 $1.81 | ▲ +3.72% | ▲ +4.93% | $1.48 (+21.28%) |
Sep 25, 2026 4w ago | Press Release | $1.88 $1.81 | ▼ −3.72% | ▼ −4.93% | $1.48 (−21.28%) |
Sep 24, 2026 4w ago | 6-K | $2.02 $1.76 | ▼ −12.87% | ▼ −12.46% | $1.48 (−26.73%) |
Aug 13, 2026 10w ago | 6-K | $1.76 $1.76 | · 0.00% | ▲ +1.96% | $1.48 (−15.91%) |
Aug 13, 2026 10w ago | Press Release | $1.76 $1.76 | · 0.00% | ▲ +1.96% | $1.48 (−15.91%) |
Jul 2, 2026 16w ago | 6-K | $2.12 $1.86 | ▲ +12.26% | ▲ +13.19% | $1.48 (+30.19%) |
Jun 1, 2026 21w ago | 6-K | $2.00 $1.81 | ▲ +9.50% | ▲ +6.54% | $1.48 (+26.00%) |
May 27, 2026 21w ago | EFFECT | $2.07 $1.91 | ▼ −7.73% | ▼ −8.20% | $1.48 (−28.50%) |
May 26, 2026 22w ago | 6-K | $2.07 $2.00 | ▼ −3.38% | ▼ −4.59% | $1.48 (−28.50%) |
May 22, 2026 22w ago | 6-K | $2.13 $2.00 | ▲ +6.10% | ▲ +7.32% | $1.48 (+30.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers